We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
-6.28%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$34.5B
AUM Growth
-$9.22B
(-21%)
Cap. Flow
-$7.24B
Cap. Flow
% of AUM
-20.99%
Top 10 Holdings %
Top 10 Hldgs %
18.89%
Holding
8,640
New
1,474
Increased
2,846
Reduced
2,852
Closed
1,160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arm
ARM
|
+$49.7M |
| 2 |
Robinhood
HOOD
|
+$25.4M |
| 3 |
Newmont
NEM
|
+$24.6M |
| 4 |
NextEra Energy
NEE
|
+$24.3M |
| 5 |
Micron Technology
MU
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$32.9M |
| 2 |
Eli Lilly
LLY
|
+$31M |
| 3 |
GXO Logistics
GXO
|
+$30.4M |
| 4 |
Wells Fargo
WFC
|
+$29.7M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.54% |
| 2 | Financials | 0.95% |
| 3 | Healthcare | 0.88% |
| 4 | Consumer Discretionary | 0.66% |
| 5 | Industrials | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALLK
6251
DELISTED
Allakos
ALLK
| $10.1K | ﹤0.01% |
44,558
-73,595
| -62% | -$33.2K |
|
6252
CALL
Monro
MNRO
$398M
| $10.1K | ﹤0.01% |
700
-900
| -56% | -$17.2K |
|
6253
CALL
Encompass Health
EHC
$12.4B
| $10.1K | ﹤0.01% |
+100
| New | +$9.76K |
|
6254
ProShares UltraShort Energy
DUG
$22M
| $10.1K | ﹤0.01% |
299
| – | – |
|
6255
CALL
Galectin Therapeutics
GALT
$348M
| $10.1K | ﹤0.01% |
8,300
-673,400
| -99% | -$945K |
|
6256
CALL
RxSight
RXST
$260M
| $10.1K | ﹤0.01% |
400
-32,600
| -99% | -$969K |
|
6257
CALL
RELX
RELX
$62B
| $10.1K | ﹤0.01% |
+200
| New | +$9.79K |
|
6258
Sypris Solutions
SYPR
$46.7M
| $10.1K | ﹤0.01% |
+6,247
| New | +$12.1K |
|
6259
CALL
Forum Energy Technologies
FET
$835M
| $10.1K | ﹤0.01% |
+500
| New | +$9.24K |
|
6260
PUT
Customers Bancorp
CUBI
$2.77B
| $10K | ﹤0.01% |
200
-19,900
| -99% | -$1.04M |
|
6261
Worthington Enterprises
WOR
$2.86B
| $10K | ﹤0.01% |
+200
| New | +$8.43K |
|
6262
PUT
Castle Biosciences
CSTL
$979M
| $10K | ﹤0.01% |
500
-600
| -55% | -$14.9K |
|
6263
PUT
Financial Institutions
FISI
$821M
| $9.98K | ﹤0.01% |
+400
| New | +$10.8K |
|
6264
CALL
Xometry
XMTR
$5.34B
| $9.97K | ﹤0.01% |
400
-1,300
| -76% | -$40.8K |
|
6265
CALL
International Seaways
INSW
$4.57B
| $9.96K | ﹤0.01% |
300
-41,500
| -99% | -$1.52M |
|
6266
Acacia Research
ACTG
$470M
| $9.94K | ﹤0.01% |
+3,106
| New | +$12.7K |
|
6267
PUT
Flex
FLEX
$44.8B
| $9.92K | ﹤0.01% |
300
-17,200
| -98% | -$674K |
|
6268
CALL
Certara
CERT
$1.25B
| $9.9K | ﹤0.01% |
1,000
| – | – |
|
6269
HDFC Bank
HDB
$121B
| $9.9K | ﹤0.01% |
+298
| New | +$9.09K |
|
6270
PUT
Addus HomeCare
ADUS
$2.23B
| $9.89K | ﹤0.01% |
+100
| New | +$11.1K |
|
6271
PUT
A2Z Smart Technologies
AZ
$277M
| $9.88K | ﹤0.01% |
+1,400
| New | +$9.72K |
|
6272
CALL
i3 Verticals
IIIV
$342M
| $9.87K | ﹤0.01% |
+400
| New | +$10.1K |
|
6273
CALL
Vontier
VNT
$4.74B
| $9.86K | ﹤0.01% |
300
-100
| -25% | -$3.64K |
|
6274
GameSquare
GAME
$37.3M
| $9.84K | ﹤0.01% |
16,542
| – | – |
|
|
EEX
6275
CALL
DELISTED
Emerald Holding
EEX
| $9.82K | ﹤0.01% |
+2,500
| New | +$10.8K |
|
Similar funds
SCP
Group One Trading's Q1 2025 Portfolio in Review
As of Q1 2025, Group One Trading held 8,640 positions worth $34.5B, down 21% from $43.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Group One Trading withdrew a net $7.24B in Q1 2025, closing 1,160 positions and reducing 2,852 holdings. Its most notable exit was Madrigal Pharmaceuticals, an estimated $32.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.5% of assets, up from 1.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Group One Trading opened a new position in Arm worth $38M.
- Group One Trading's largest Q1 2025 buy was Arm: 356,137 shares worth $38M.
- Group One Trading added most to Robinhood in Q1 2025, an estimated $25.4M increase.
- Group One Trading's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $31M.
- Group One Trading fully exited Madrigal Pharmaceuticals in Q1 2025, selling an estimated $32.9M.
- Group One Trading's ten largest holdings make up 19% of its $34.5B portfolio in Q1 2025.
- Group One Trading opened 1,474 new positions and closed 1,160 in Q1 2025.
- Group One Trading's portfolio value fell 21% quarter-over-quarter to $34.5B.
Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.